Clinical Trial of Measles, Mumps and Rubella Combined Vaccine, Live

Clinical trial NCT05161845 · COMPLETED

Trial details

NCT number: NCT05161845
Sponsor: Shanghai Institute Of Biological Products
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Immunotoxicity Vaccine

Start date: 2021-12-23
Primary completion: 2022-04-04
Enrollment: 1068

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.